HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine G Schnackenberg Selected Research

5- (4- (trimethylammonium)phenyl)- 10,15,20- tris(2,4,6- trimethoxyphenyl)porphyrin

1/2013Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine G Schnackenberg Research Topics

Disease

6Hypertension (High Blood Pressure)
01/2013 - 02/2002
4Hypertrophy
08/2021 - 07/2007
3Cardiovascular Diseases (Cardiovascular Disease)
08/2021 - 01/2012
2Cardiomegaly (Heart Hypertrophy)
01/2014 - 01/2012
2Insulin Resistance
01/2013 - 03/2008
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 03/2008
2Dyslipidemias (Dyslipidemia)
01/2013 - 03/2008
1Cardio-Renal Syndrome
08/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
08/2021
1Fibrosis (Cirrhosis)
08/2021
1Reperfusion Injury
05/2017
1type 2C Congenital disorder of glycosylation
03/2017
1Heart Diseases (Heart Disease)
01/2014
1Body Weight (Weight, Body)
01/2013
1Hypertriglyceridemia
01/2013
1Glucose Intolerance
01/2013
1Pulmonary Edema
11/2012
1Myocardial Infarction
11/2012
1Ischemia
01/2012
1Stroke (Strokes)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
09/2008
1Obesity
03/2008
1Heart Failure
07/2007
1Right Ventricular Hypertrophy
07/2007
1Infarction (Infarctions)
07/2007
1Diabetes Mellitus
02/2002

Drug/Important Bio-Agent (IBA)

3Angiotensin IIIBA
05/2017 - 09/2002
2TRPC6 Cation ChannelIBA
01/2014 - 09/2013
2GlucocorticoidsIBA
01/2013 - 09/2008
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2007 - 02/2002
1Fibroblast Growth Factor-23IBA
08/2021
1Phosphates (Orthophosphate)IBA
08/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2021
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
05/2017
1halofuginoneIBA
05/2017
1CalciumIBA
03/2017
1Pharmaceutical PreparationsIBA
01/2014
1Endothelin-1 (Endothelin 1)IBA
01/2014
1ThiazolesIBA
09/2013
1AmidesIBA
09/2013
15- (4- (trimethylammonium)phenyl)- 10,15,20- tris(2,4,6- trimethoxyphenyl)porphyrinIBA
01/2013
1Hydroxysteroid DehydrogenasesIBA
01/2013
1ReninIBA
01/2013
1GSK2193874IBA
11/2012
1SaltsIBA
01/2012
1BAY 60-4552IBA
01/2012
1Soluble Guanylyl CyclaseIBA
01/2012
1EnzymesIBA
09/2008
1Androgen Receptors (Androgen Receptor)IBA
09/2008
1AndrogensIBA
09/2008
1serum-glucocorticoid regulated kinaseIBA
09/2008
111-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA
03/2008
111-beta-Hydroxysteroid Dehydrogenase Type 1IBA
03/2008
1ElectrolytesIBA
03/2008
1PPAR deltaIBA
07/2007
1A 7 (A-7)IBA
07/2007
1Natriuretic PeptidesIBA
07/2007
1Proteins (Proteins, Gene)FDA Link
05/2007
1tempolIBA
05/2007
1NADPH Oxidases (NAD(P)H oxidase)IBA
05/2007
18-epi-prostaglandin F2alphaIBA
05/2007
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
05/2007
1des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
09/2002
1Plasminogen Activator Inhibitor 1IBA
09/2002

Therapy/Procedure

1Nephrectomy
08/2021
1Drug Therapy (Chemotherapy)
09/2008